Skip to main content
CHE $532.88 -0.80%
CHE logo

CHE · Chemed Corp

Track CHE — free
$532.88 -4.29 (-0.80%) At close · Aug 14
Market Cap
$6.96B
Shares
13.07M
All earnings calls

Earnings call · FY2024 Q3

Chemed Corp Q3 FY2024 Earnings Call

Chemed Corp Q3 FY2024 Earnings Call

Concluded Oct 29, 2024
Oct 29, 2024 28 turns
Period
FY2024 Q3
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Roto-Rooter revenue decline 51 VITAS Healthcare strong performance 41 2025 outlook and guidance 39 Search engine marketing transition 19 Covenant Health acquisition integration 15 Medicare reimbursement rate 5

Management tone

Balanced

Net tone +5 · moderate hedging

Grounding quotes
  • “We continue to be disappointed in Roto-Rooter's results.”
  • “We are cautious about 2025.”
  • “we are very bullish on the prospects for VITAS for the remainder of 2024 and beyond”
  • “tough sledding to get there, no question”

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $606.18M +7.4% YoY
Diluted EPS $5.00 +1.4% YoY
Net income $75.78M +1.1% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Segment Vitas$391.41M
Segment Roto Rooter$214.78M -6.9% YoY

Capital returned

Buybacks · derived
$57.82M
Shares repurchased
100,000
Dividend / share
$0.50
Full-screen source Call document